Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats

被引:33
|
作者
Terzian, Ana Luisa B. [1 ,2 ]
dos Reis, Daniel Gustavo [3 ]
Guimares, Francisco S. [3 ,4 ]
Correa, Fernando M. A. [3 ]
Resstel, Leonardo B. M. [3 ,4 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, BR-14049900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Contextual fear; TRPV1; receptors; Prefrontal cortex; Cardiovascular system; Rats; CARDIOVASCULAR-RESPONSES; REVERSIBLE INACTIVATION; ENDOCANNABINOID SYSTEM; SYNAPTIC-TRANSMISSION; EMOTIONAL RESPONSES; INFRALIMBIC CORTEX; PRELIMBIC CORTEX; ANXIETY; MODULATION; LESIONS;
D O I
10.1007/s00213-013-3211-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Contextual fear is evoked by re-exposing an animal to an environment that has been previously paired with an aversive or unpleasant stimulus. It can be assessed by freezing and cardiovascular changes such as increase in mean arterial pressure and heart rate. A marked increase in neuronal activity is associated with contextual fear conditioning, especially in limbic structures involved with defense reactions, such as the ventral portion of medial prefrontal cortex. Given the fact that transient receptor potential vanilloid type 1 (TRPV1) receptors could be involved in the expression of defensive behavior, the present work tested the hypothesis that TRPV1 manipulation in the ventromedial prefrontal cortex (vMPFC) modulates the expression of contextual conditioned fear. Male Wistar rats received bilateral microinjections into the vMPFC of the TRPV1 receptor antagonists capsazepine (1, 10, and 60 nmol/200 nL) or 6-iodonordihydrocapsaicin (3 nmol/200 nL), and the TRPV1 agonist capsaicin (1 nmol/200 nL) preceded by vehicle or 6-iodonordihydrocapsaicin before re-exposure to the experimental chamber for 10 min, 48 h after conditioning in two different protocols distinct by their aversiveness. Both antagonists reduced the freezing and cardiovascular responses in the high aversive protocol. Capsaicin caused an increase in fear-associated responses that could be blocked by 6-iodonordihydrocapsaicin. Our results indicate that TRPV1 receptors located in the vMPFC have a tonic involvement in the modulation of the expression of contextual fear conditioning.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 50 条
  • [21] Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis
    Engler, Andrea
    Aeschlimann, Andre
    Simmen, Beat R.
    Michel, Beat A.
    Gay, Renate E.
    Gay, Steffen
    Sprott, Haiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 359 (04) : 884 - 888
  • [22] Increased Transient Receptor Potential Vanilloid Type 1 (TRPV1) Signaling in Idiopathic Overactive Bladder Urothelial Cells
    Li, Mingkai
    Sun, Yan
    Simard, J. Marc
    Chai, Toby C.
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (04) : 606 - 611
  • [23] Gastric Carcinogenesis and Potential Role of the Transient Receptor Potential Vanilloid 1 (TRPV1) Receptor: An Observational Histopathological Study
    Groen, Sylvester R.
    Keszthelyi, Daniel
    Szallasi, Arpad
    van Veghel, Jara A.
    Alleleyn, Annick M. E.
    Cseko, Kata
    Helyes, Zsuzsanna
    Samarska, Iryna
    Grabsch, Heike I.
    Masclee, Ad A. M.
    Weerts, Zsa Zsa R. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [24] Discovery of novel pyrrolopyridazine scaffolds as transient receptor potential vanilloid (TRPV1) antagonists
    Dorange, Ismet
    Forsblom, Rickard
    Macsari, Istvan
    Svensson, Mats
    Bylund, Johan
    Besidski, Yevgeni
    Blid, Jan
    Sohn, Daniel
    Gravenfors, Ylva
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (22) : 6888 - 6895
  • [25] Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats
    Casarotto, Plinio C.
    Terzian, Ana Luisa B.
    Aguiar, Daniele C.
    Zangrossi, Helio
    Guimaraes, Francisco S.
    Wotjak, Carsten T.
    Moreira, Fabricio A.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (02) : 478 - 486
  • [26] The Transient Receptor Potential Vanilloid Receptor 1, TRPV1 (VR1) Inhibits Peristalsis in the Mouse Jejunum
    Rahmati, Reza
    ARCHIVES OF IRANIAN MEDICINE, 2012, 15 (07) : 433 - 438
  • [27] Differences in the acidic sensitivity of transient receptor potential vanilloid 1 (TRPV1) between chickens and mice
    Liang, Ruojun
    Kawabata, Yuko
    Kawabata, Fuminori
    Nishimura, Shotaro
    Tabata, Shoji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (02) : 386 - 393
  • [28] Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats
    Ravnefjord, Anna
    Brusberg, Mikael
    Kang, Daiwu
    Bauer, Udo
    Larsson, Hakan
    Lindstrom, Erik
    Martinez, Vicente
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 611 (1-3) : 85 - 91
  • [29] Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic
    Ann, Jihyae
    Kim, Ho Shin
    Thorat, Shivaji A.
    Kim, Hee
    Ha, Hee-Jin
    Choi, Kwanghyun
    Kim, Young-Ho
    Kim, Minseok
    Hwang, Sun Wook
    Pearce, Larry, V
    Esch, Timothy E.
    Turcios, Noe A.
    Blumberg, Peter M.
    Lee, Jeewoo
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) : 418 - 424
  • [30] Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray
    Terzian, Ana Luisa B.
    Aguiar, Daniele C.
    Guimaraes, Francisco S.
    Moreira, Fabricio A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (03) : 188 - 195